Browse

Proliposomes for enhanced oral bioavailability of BCS class II drugs
향상된 경구 생체이용률을 위한 BCS class II 약물의 프로리포솜 적용 :

DC Field Value Language
dc.contributor.advisor김대덕-
dc.contributor.author전다은-
dc.date.accessioned2017-07-19T11:22:16Z-
dc.date.available2017-07-19T11:22:16Z-
dc.date.issued2016-02-
dc.identifier.other000000131112-
dc.identifier.urihttp://hdl.handle.net/10371/133607-
dc.description학위논문 (석사)-- 서울대학교 대학원 : 약학대학 약학과 약제과학 전공, 2016. 2. 김대덕.-
dc.description.abstractPurpose. The aim of this study was to develop a simple preparation method of proliposomes (PLs) with a high lipid content, and to characterize and evaluate the BCS class II drug-loaded PLs (valsartan-loaded PLs (VSTPLs) and celecoxib-loaded PLs (CXBPLs)) in vitro and in vivo for their suitability for oral delivery.
Methods. Rotary evaporator and freeze dryer were used to prepare PLs. Maximum lipid contents of PLs which can form liposomes after reconstitution were determined. After loading drugs, the solid state of PLs was also characterized by scanning electron microscopy (SEM), powder X-ray diffractometer (PXRD) and differential scanning calorimetry (DSC). PLs were reconstituted with distilled water, and then were characterized by measuring the particle size, zeta potential, entrapment efficiency (EE), and drug content. Particle morphology of reconstituted liposomes was determined by transmission electron microscopy (TEM). In vitro dissolution and in vivo pharmacokinetics of PLs in rats were also evaluated.
Results. Phospholipid content of the PLs was increased up to 20% (w/w), thereby being able to enhance the drug loading content. Crystalline state of the drug was transformed to amorphous state during the preparation of PLs. Particle size of reconstituted VST-loaded liposomes and CXB-loaded liposomes were 369 ± 31 nm and 537 ± 10 nm with the zeta potential of -57.4 ± 0.4 mV and –64.2 ± 0.3 mV, respectively. The EE values of VST and CXB were 77.5 ± 2.8% and 84.7 ± 1.2% for VST-loaded liposomes and CXB-loaded liposomes, respectively. The rate and extent of dissolution of drugs from the PLs were higher than those of crude drug powder in various pHs. In pharmacokinetic studies after oral administration in rats, drugs in PLs showed higher Cmax values and 1.82-fold and 1.73-fold higher AUC values for VSTPLs and CXBPLs, respectively, than those from the drug powder. Shorter Tmax was shown in CXBPLs than that of crude drug powder.
Conclusions. The preparation method of PLs developed in this study has the following advantages compared with conventional preparation methods: (a) the preparation method is simple and could be easily scaled up, (b) the solvent system used has no toxicity concern, (c) the PLs have a higher lipid content, which can enhance the incorporation of poorly water-soluble drugs, (d) the rapid formation of liposomes in aqueous media and the amorphous state of the drug in PLs can increase solubility and dissolution rate, thereby increase oral bioavailability of the drug.
-
dc.description.tableofcontents1. Introduction 1
2. Materials and methods 4
2.1 Materials 4
2.2 Preparation of proliposomes (PLs) 4
2.3 Characterization of PLs 5
2.3.1 Solid state characterization 5
2.3.1.1 Field emission scanning electron microscopy (FESEM) 5
2.3.1.2 Differential scanning claorimetry (DSC) 5
2.3.1.3 Powder X-ray diffractometry (PXRD) 6
2.3.2 Characterization of liposomes 6
2.3.2.1 Tranmission electron microscopy (TEM) 6
2.3.2.2 Particle size and zeta potential 6
2.3.2.3 Determination of drug content and entrapment efficiency (EE) 7
2.4 In vitro dissolution studies 8
2.4.1 In vitro dissolution studies of VSTPLs 8
2.4.2 In vitro dissolution studies of CXBPLs 9
2.5 In vivo pharmacokinetic studies 10
2.5.1 In vivo pharmacokinetic studies of VSTPLs 10
2.5.2 In vivo pharmacokinetic studies of CXBPLs 11
2.5.3 Pharmacokinetic parameters 13
2.6 Statistical Analysis 13
3. Result and discussion 14
3.1 Preparation of proliposomes (PLs) 14
3.2 Characterization of PLs 15
3.2.1 Solid state characterization 15
3.2.2 Characterization of liposomes 17
3.3 In vitro dissolution studies 17
3.3.1 In vitro dissolution studies of VSTPLs 17
3.3.2 In vitro dissolution studies of CXBPLs 18
3.4 In vivo pharmacokinetic studies 19
3.4.1 In vivo pharmacokinetic studies of VSTPLs 19
3.4.2 In vivo pharmacokinetic studies of CXBPLs 20
4. Conclusions 22
5. References 23
Supplementary Information 40
국문초록 49
-
dc.formatapplication/pdf-
dc.format.extent12913482 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectProliposomes-
dc.subjectValsartan-
dc.subjectCelecoxib-
dc.subjectDissolution rate-
dc.subjectOral bioavailability-
dc.subject.ddc615-
dc.titleProliposomes for enhanced oral bioavailability of BCS class II drugs-
dc.title.alternative향상된 경구 생체이용률을 위한 BCS class II 약물의 프로리포솜 적용 :-
dc.typeThesis-
dc.contributor.AlternativeAuthorDaeun Jeon-
dc.description.degreeMaster-
dc.citation.pages51-
dc.contributor.affiliation약학대학 약학과-
dc.date.awarded2016-02-
Appears in Collections:
College of Pharmacy (약학대학)Dept. of Pharmacy (약학과)Theses (Master's Degree_약학과)
Files in This Item:
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse